Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis.
about
Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issuesRecent advances in prenatal genetic screening and testingAntisense oligonucleotides delivered to the amniotic cavity in utero modulate gene expression in the postnatal mouse.Development and evaluation of training resources to prepare health professionals for counselling pregnant women about non-invasive prenatal testing for Down syndrome: a mixed methods studyThe maternal age-related first trimester risks for trisomy 21, 18 and 13 based on Danish first trimester data from 2005 to 2014.Knowledge and Attitudes Regarding Non-Invasive Prenatal Testing (NIPT) and Preferences for Risk Information among High School Students in SwedenNoninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United StatesCopy number variants, aneuploidies, and human diseaseFetal Genotyping in Maternal Blood by Digital PCR: Towards NIPD of Monogenic Disorders Independently of Parental OriginPositive Attitudes towards Non-Invasive Prenatal Testing (NIPT) in a Swedish Cohort of 1,003 Pregnant WomenAnalysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.Statistical Approach to Decreasing the Error Rate of Noninvasive Prenatal Aneuploid Detection caused by Maternal Copy Number VariationTargeted capture enrichment assay for non-invasive prenatal testing of large and small size sub-chromosomal deletions and duplicationsFirst trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.Maternal anxiety and its correlation with pain experience during chorion villus sampling and amniocentesis.Cell-free DNA versus intact fetal cells for prenatal genetic diagnostics: what does the future hold?How to perform transabdominal chorionic villus sampling: a practical guideline.The yield and complications of amniocentesis performed after 24 weeks of gestation.Fetal aneuploidy screening with cell-free DNA in late gestation.Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods.Is there a Role for Genetic Counselors in Prenatal Paternity Testing? - an Assessment Based on Audit of 13 years of Clinical Experience in South Australia.First trimester contingent screening for trisomies 21,18,13: is this model cost efficient and feasible in public health system?Prenatal Diagnosis: Screening and Diagnostic Tools.Chorionic villous sampling through transvaginal ultrasound approach: A retrospective analysis of 1138 cases.Gestation related karyotype, QF-PCR and CGH-array failure rates in diagnostic amniocentesis.Genetic Counseling in Primary Immunodeficiency Disorders: An Emerging Experience in Egypt.Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies.QUAD versus cfDNA in an urban population in the second trimester for detection of trisomy 21: a cost sensitivity analysis.Frequency of fetal karyotype abnormalities in women undergoing invasive testing in the absence of ultrasound and other high-risk indications.Emerging issues in invasive prenatal diagnosis: Safety and competency in the post-NIPT era.Amniotic fluid rapid biomarkers are associated with intra-amniotic infection in preterm pregnancies regardless of the membrane status.Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis.Detection of fetal chromosomal anomalies: does nuchal translucency measurement have added value in the era of non-invasive prenatal testing?Challenges of Pre- and Post-Test Counseling for Orthodox Jewish Individuals in the Premarital Phase.First trimester contingent testing with either nuchal translucency or cell-free DNA. Cost efficiency and the role of ultrasound dating.Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.Implementing non-invasive prenatal testing into publicly funded antenatal screening services for Down syndrome and other conditions in Aotearoa New Zealand.Cell-free fetal DNA: the new tool in fetal medicinePrenatal diagnosis for haemophilia: the Thai experience.
P2860
Q26764809-1D549897-5798-4CA2-A772-0FF0C012D086Q28071888-8429FA4E-4382-4A7B-94EB-8E4652A375A9Q30832682-25550BC2-AA77-4366-8ABD-2D3654CA4D03Q30847203-F6DE9988-94AB-41DA-8F24-2B9E1DFAF078Q31089104-517DC742-3602-483C-9E3E-380AD4D125BDQ33634135-2A0BD9C5-059B-48CE-8A6C-2C317791CF9AQ34535626-E3A34AEF-EAFF-42F6-97CD-F799A1A655D7Q35680437-C0D3B927-8BEE-4133-9E85-772BF41614CCQ35694174-84A6081E-17B8-45C9-BAC0-2340737F3E34Q35990077-0A73AF08-07F8-46EA-9327-B6CE2DFCE28EQ36022080-5AC2A66B-E853-4D90-ABE1-679F95D883B5Q36173927-156D243A-980A-46B7-BF19-184B4E9E4AD6Q36245906-55E45D93-144E-4039-ABA1-5AFA89E43962Q36269719-69FB1305-8DFF-436B-901B-6B59B9841BDEQ36308489-84284EA2-46AB-421F-B16A-B6E8DC00B4ECQ37709543-E0596F06-36BD-4DF1-88D0-1B66E898BD76Q38509263-ABCE0AB1-F3A6-47AE-B9BB-2AAADD23B4E8Q38587244-39FE796C-2C41-4948-A61F-886A2456643EQ38765977-9221DCB5-5FD0-47CD-B207-3E623D57A829Q38819938-38ABB6CA-9EAC-4B25-A43D-92DBD4E05C12Q38895114-44DCCAC7-0BD4-45CA-9CF1-9FE31A540C8EQ38904454-49CF0BDD-FAF7-4B7E-992D-0AF5E9F8E860Q39132795-6841F7DF-AF8E-4EE0-849F-89E0B57CBB38Q39302986-5D246F29-7624-414C-B6CE-42D23BD4D711Q39648510-BF2BD402-1913-49B7-A636-4E89386A54C6Q39756897-9E056F70-C270-4E25-AB0E-4B5CE450707EQ40049858-CD667DC8-9052-48BC-8B57-DB7004C0A7CFQ40307444-4C0D3FE2-AEF0-453C-8A65-7DFB40E580C6Q40413919-DD250B22-6D85-432D-8CBB-42015C2DAAA6Q40524568-522CED58-85BF-4C82-B6ED-BC3F22C1A9CCQ40612012-803E0B68-381F-4442-B9E5-FBAD4247DB49Q40724581-1A49FE4B-5FC9-4500-8F85-9C108834EE21Q41235376-E5BAD395-DA2E-4B85-B6DB-79FEDCB3BA34Q41260566-58D1129A-3C50-4387-905F-F2FCDB6C249EQ41382663-5A8FA793-417B-430F-8FEC-88004FBC3B7EQ41592901-27E36355-3823-4AF3-A3FB-A87A6A554E0EQ41611034-12068D1C-72BF-448A-8A59-B68D360EB8FBQ42278993-EA623934-381A-4CAB-96D8-AB5763457ABBQ42393162-1B7B91F8-EB3A-4066-8B7B-F85E43004DBFQ45855679-EA51BB1A-ADCD-4AE6-9A7C-1CB1E2C73E70
P2860
Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Procedure-related risk of misc ...... atic review and meta-analysis.
@ast
Procedure-related risk of misc ...... atic review and meta-analysis.
@en
type
label
Procedure-related risk of misc ...... atic review and meta-analysis.
@ast
Procedure-related risk of misc ...... atic review and meta-analysis.
@en
prefLabel
Procedure-related risk of misc ...... atic review and meta-analysis.
@ast
Procedure-related risk of misc ...... atic review and meta-analysis.
@en
P2093
P2860
P356
P1476
Procedure-related risk of misc ...... atic review and meta-analysis.
@en
P2093
P2860
P356
10.1002/UOG.14636
P577
2015-01-01T00:00:00Z